Imazaquin

CASRN 81335-37-7

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (7 pp, 86 K) last updated: 01/31/1987

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
2.5 x10-1 Immune, Hepatic, Hematologic, Other Decreased body weight gain, skeletal myopathy, slight anemia, bone marrow hyperplasia, elevated serum SGOT, SGPT, CPK NOEL : 2.5 x101
mg/kg-day
100 High

Reference Concentration for Inhalation Exposure (RfC) (PDF) (7 pp, 86 K)
Not assessed under the IRIS Program.

Cancer Assessment


Weight of Evidence for Cancer (PDF) (7 pp, 86 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (7 pp, 86 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (7 pp, 86 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.